10-K/A XBRL

FORM 10-K/A

Company: TENAX THERAPEUTICS, INC.
Filed: April 16, 2021
Period of Report: December 31, 2020
Accession Number: 0001654954-21-004297

View Document ↗ View on SEC.gov ↗